Annual Gross Margin
46.77%
-28.60%-37.95%
December 31, 2022
Summary
- As of February 27, 2025, SRNE annual gross profit margin is 46.77%, with the most recent change of -28.60% (-37.95%) on December 31, 2022.
- During the last 3 years, SRNE annual gross margin has fallen by -14.30% (-23.42%).
- SRNE annual gross margin is now -52.82% below its all-time high of 99.13%, reached on December 31, 2013.
Performance
SRNE Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
43.74%
-24.35%-35.76%
June 30, 2023
Summary
- As of February 27, 2025, SRNE quarterly gross profit margin is 43.74%, with the most recent change of -24.35% (-35.76%) on June 30, 2023.
- Over the past year, SRNE quarterly gross margin has dropped by -24.35% (-35.76%).
- SRNE quarterly gross margin is now -58.93% below its all-time high of 106.49%, reached on December 31, 2016.
Performance
SRNE Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
SRNE Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | -35.8% |
| 3 y3 years | -23.4% | -35.8% |
| 5 y5 years | -52.0% | -35.8% |
SRNE Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.0% | at low | -42.5% | +264.5% |
| 5 y | 5-year | -38.0% | at low | -50.9% | +264.5% |
| alltime | all time | -52.8% | +0.4% | -58.9% | +358.0% |
Sorrento Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 43.74%(-35.8%) |
| Mar 2023 | - | 68.09%(+467.4%) |
| Dec 2022 | 46.77%(-37.9%) | 12.00%(-77.1%) |
| Sep 2022 | - | 52.48%(+4.5%) |
| Jun 2022 | - | 50.23%(-26.9%) |
| Mar 2022 | - | 68.68%(-9.6%) |
| Dec 2021 | 75.37%(+0.3%) | 76.01%(+5.7%) |
| Sep 2021 | - | 71.92%(-6.5%) |
| Jun 2021 | - | 76.90%(+0.9%) |
| Mar 2021 | - | 76.25%(-1.7%) |
| Dec 2020 | 75.14%(+23.0%) | 77.57%(+0.4%) |
| Sep 2020 | - | 77.27%(+3.0%) |
| Jun 2020 | - | 75.03%(+9.7%) |
| Mar 2020 | - | 68.41%(-23.2%) |
| Dec 2019 | 61.07%(-8.4%) | 89.09%(+832.9%) |
| Sep 2019 | - | 9.55%(-80.6%) |
| Jun 2019 | - | 49.34%(-21.0%) |
| Mar 2019 | - | 62.43%(-5.6%) |
| Dec 2018 | 66.69% | 66.16%(+40.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | 46.97%(-31.6%) |
| Jun 2018 | - | 68.67%(-13.1%) |
| Mar 2018 | - | 79.01%(-17.0%) |
| Dec 2017 | 97.40%(+8.2%) | 95.20%(-3.9%) |
| Sep 2017 | - | 99.11%(+20.1%) |
| Jun 2017 | - | 82.51%(+5.6%) |
| Mar 2017 | - | 78.17%(-26.6%) |
| Dec 2016 | 90.05%(+56.6%) | 106.49%(+30.9%) |
| Sep 2016 | - | 81.36%(+20.9%) |
| Jun 2016 | - | 67.29%(+5.7%) |
| Mar 2016 | - | 63.66%(+4.6%) |
| Dec 2015 | 57.52%(+23.5%) | 60.88%(+34.6%) |
| Sep 2015 | - | 45.24%(-38.2%) |
| Jun 2015 | - | 73.23%(+52.9%) |
| Mar 2015 | - | 47.90%(+7.7%) |
| Dec 2014 | 46.59%(-53.0%) | 44.49%(-24.2%) |
| Sep 2014 | - | 58.70%(+71.7%) |
| Jun 2014 | - | 34.19%(-19.2%) |
| Mar 2014 | - | 42.32%(-55.9%) |
| Dec 2013 | 99.13% | 96.04% |
FAQ
- What is Sorrento Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual gross margin year-on-year change?
- What is Sorrento Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly gross margin year-on-year change?
What is Sorrento Therapeutics annual gross profit margin?
The current annual gross margin of SRNE is 46.77%
What is the all time high annual gross margin for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual gross profit margin is 99.13%
What is Sorrento Therapeutics annual gross margin year-on-year change?
Over the past year, SRNE annual gross profit margin has changed by -28.60% (-37.95%)
What is Sorrento Therapeutics quarterly gross profit margin?
The current quarterly gross margin of SRNE is 43.74%
What is the all time high quarterly gross margin for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly gross profit margin is 106.49%
What is Sorrento Therapeutics quarterly gross margin year-on-year change?
Over the past year, SRNE quarterly gross profit margin has changed by -24.35% (-35.76%)